Procedural and outcome information
| Parameter | Total (n=156) | Heart failure (−) (n=144) | Heart failure (+) (n=12) | P value |
| Procedural data | ||||
| Access route | 0.067 | |||
| Transfemoral | 133 (85.3) | 125 (86.8) | 8 (66.7) | |
| Transapical | 20 (12.8) | 17 (11.8) | 3 (25.0) | |
| Transsubcravian | 1 (0.6) | 1 (0.7) | 0 (0.0) | |
| Direct-Aorta | 2 (1.3) | 1 (0.7) | 1 (8.3) | |
| Valve type | 0.753 | |||
| Edwards SAPIEN XT | 46 (29.5) | 43 (29.9) | 3 (25.0) | |
| Edwards SAPIEN 3 | 93 (59.6) | 86 (59.7) | 7 (58.3) | |
| Medtronic corevalve | 3 (1.9) | 3 (2.1) | 0 (0.0) | |
| Medtronic EvolutR | 14 (9.0) | 12 (8.3) | 2 (16.7) | |
| Valve size (mm) | 23 (23–26) | 23 (23–26) | 23 (23–26) | 0.604 |
| Urgency | 20 (12.8) | 16 (11.1) | 4 (33.3) | 0.027 |
| Simultaneous catheter measurement | ||||
| Mean AVPG before TAVI | 48 (36–66) | 48 (35–66) | 65 (57–96) | 0.034 |
| Mean AVPG after TAVI | 7 (5–11) | 7 (5–11) | 8 (6–9) | 0.795 |
| Mean AVPG improvement | 40 (30–59) | 39 (29–57) | 60 (49–85) | 0.023 |
| LVEDP before TAVI | 17 (14–23) | 17 (14–23) | 21 (15–24) | 0.474 |
| LVEDP after TAVI | 20 (13–25) | 20 (14–25) | 16 (10–24) | 0.529 |
| PVL grade after TAVI | 0.162 | |||
| None | 26 (18.6) | 26 (20.0) | 0 (0.0) | |
| Trace | 79 (56.4) | 70 (53.8) | 9 (90.0) | |
| Mild | 34 (24.3) | 33 (25.4) | 1 (10.0) | |
| Moderate | 1 (0.7) | 1 (0.8) | 0 (0.0) | |
| Severe | 0 (0.0) | 0 (0.0) | 0 (0.0) | |
| Contrast (mL) | 66 (57–84) | 66 (56–84) | 66 (59–74) | 0.878 |
| Fluoroscopy time (min) | 19 (13–29) | 19 (13–29) | 21 (12–25) | 0.939 |
| Procedure time (min) | 72 (50–102) | 71 (50–101) | 93 (51–129) | 0.333 |
| Anaesthesia time (min) | 132 (109–165) | 132 (109–162) | 153 (119–188) | 0.212 |
| Volume of infusion (mL) | 1300 (838–1623) | 1290 (800–1603) | 1595 (925–2490) | 0.204 |
| Blood transfusion (mL) | 0 (0–280) | 0 (0–280) | 140 (0–615) | 0.073 |
| In-out balance (mL) | 950 (565–1405) | 940 (550–1355) | 1395 (785–1940) | 0.107 |
| Periprocedural complications | ||||
| In-hospital death | 2 (1.3) | 2 (1.4) | 0 (0.0) | 0.681 |
| Disabling stroke | 2 (1.3) | 2 (1.4) | 0 (0.0) | 0.681 |
| Coronary occlusion | 5 (3.2) | 5 (3.5) | 0 (0.0) | 0.512 |
| Acute kidney injury | 8 (5.1) | 7 (4.9) | 1 (8.3) | 0.600 |
| Permanent pacemaker implantation | 7 (4.5) | 6 (4.2) | 1 (8.3) | 0.503 |
Caption is the same as in table 1.
AVPG, aortic valve pressure gradient; LVEDP, left ventricular end diastolic pressure; PVL, paravalvular leakage; TAVI, transcatheter aortic valve implantation.